Continuing to Strengthen Inclusion Reporting on NIH-funded Phase III Trials
This reporting requirement applies to new and competing awards made on or after December 13, 2017. Findings from valid analyses based on sex/gender and race/ethnicity from these applicable NIH-defined Phase III clinical trials must now be reported in ClinicalTrials.gov within one year of completion of data collection for the study’s primary outcome measures. This builds on existing requirements for registering and reporting results in ClinicalTrials.gov. If you have an applicable NIH-defined Phase III clinical trial that was already underway before the effective date, the requirement will not affect you for your curren...
Source: NIH Extramural Nexus - January 8, 2018 Category: Research Authors: Mike Lauer Tags: blog Open Mike Clinical Trials Clinicaltrials.gov Source Type: funding
